Precision Epigenomics today announced that it has received accreditation from the College of American Pathologists (CAP), a globally recognized standard of excellence for clinical laboratory quality and performance. This milestone underscores the company’s commitment to delivering reliable, high-quality epigenomic testing and data to support research, clinical decision-making, and precision medicine initiatives.
For the full article click here: Precision Epigenomics Receives CAP Accreditation, Advancing Commitment to Quality and Clinical Excellence